Health Catalyst, Inc. (NASDAQ:HCAT) Q4 2023 Earnings Call Transcript
Health Catalyst, Inc. beats earnings expectations. Reported EPS is $0.02, expectations were $-0.01. Health Catalyst, Inc.
Health Catalyst Inc. (HCAT)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Impax Asset Management Ian Simm | 2,154,475 | $16,223,197 | +23% | 0.06% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $7.81 | 26,200 | 1,172,623 | 2024-02-27 | Filing | ||
| $10.19 | 49,050 | 919,415 | 2023-05-12 | Filing | ||
| $10.14 | 197,078 | 900,140 | 2022-11-11 | Filing | ||
| $10.99 | 90,750 | 703,062 | 2022-09-08 | Filing | ||
| $11.63 | 6,600 | 35,405 | 2022-08-19 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $6.11 | 2,005 | 126,226 | 2024-04-15 | Filing | ||
| $7.80 | 2,005 | 128,231 | 2024-03-15 | Filing | ||
| $9.77 | 3,262 | 64,786 | 2024-02-15 | Filing | ||
| $10.83 | 3,163 | 68,048 | 2024-01-16 | Filing | ||
| $8.83 | 3,163 | 71,211 | 2023-12-15 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 70,490,000 | $67,025,221 | 0.63% | |
| 2. | 53,595,000 | $51,332,104 | 0.91% | |
| 3. | 5,507,972 | $51,003,821 | 0% | |
| 4. | 5,318,571 | $49,249,968 | 0% | |
| 5. | 3,140,282 | $29,079,012 | 0% |
News See All
20 Most Valuable Digital Health Companies In The US
In this article, we will be taking a look at the 20 most valuable digital health companies in the US.
Health Catalyst, Inc. (NASDAQ:HCAT) Q3 2023 Earnings Call Transcript
Operator: Welcome to the Health Catalyst Third Quarter 2023 Earnings Conference Call.
Health Catalyst, Inc. (NASDAQ:HCAT) Q2 2023 Earnings Call Transcript
Operator: Welcome to the Health Catalyst Second Quarter 2023 Earnings Conference Call.
Here’s Why Conestoga Micro Cap Strategy Sold Health Catalyst (HCAT)
Conestoga Capital Advisors, an asset management company, released its “Micro Cap Strategy” second-quarter 2023 investor letter. A copy of the same can be downloaded here.
Health Catalyst, Inc. (NASDAQ:HCAT) Q1 2023 Earnings Call Transcript
Operator: Welcome to the Health Catalyst First Quarter 2023 Earnings Conference Call.
Health Catalyst, Inc. (NASDAQ:HCAT) Q4 2022 Earnings Call Transcript
Operator: Welcome to the Health Catalyst Fourth Quarter and Full Year 2022 Earnings Conference Call.
14 Small-Cap Stocks with High Potential
Small-cap investors took a beating in 2022 as data shows that small-cap stocks are near their all-time lows.
Should You Eliminate Health Catalyst (HCAT) From Your Portfolio?
ClearBridge Investments, an investment management company, published its “ClearBridge Small Cap Growth Strategy” third quarter 2022 investor letter. A copy of the same can be downloaded here.
10 Healthcare Stocks to Buy According to Tiger Cub Chase Coleman
In this article, we discuss 10 healthcare stocks to buy according to Tiger Cub Chase Coleman.